• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光动力疗法对中心性浆液性脉络膜视网膜病变患者视盘内侧脉络膜的影响。

Effect of photodynamic therapy on choroid of the medial area from optic disc in patients with central serous chorioretinopathy.

机构信息

Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.

Canon Inc., Tokyo, Japan.

出版信息

PLoS One. 2023 Feb 21;18(2):e0282057. doi: 10.1371/journal.pone.0282057. eCollection 2023.

DOI:10.1371/journal.pone.0282057
PMID:36809529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9942968/
Abstract

PURPOSE

To explore the effect of photodynamic therapy (PDT) on the choroid of medial area from optic disc and factors correlated with treatment outcomes, we evaluated choroidal changes using ultra-widefield optical coherence tomography (UWF-OCT) after PDT for central serous chorioretinopathy (CSC).

METHODS

In this retrospective case-series, we included CSC patients who received a standard-dose of full-fluence PDT. UWF-OCT were examined at baseline and 3 months after treatment. We measured choroidal thickness (CT), classified into central, middle, and peripheral sectors. We examined CT changes after PDT by sectors and treatment outcome.

RESULTS

Twenty-two eyes of 21 patients (20 males; mean age 58.7 ± 12.3 years) were included. CT reduction after PDT was significant in all sectors, including peripheral areas: supratemporal, 330.5 ± 90.6 μm vs. 237.0 ± 53.2 μm; infratemporal, 240.0 ± 89.4 μm vs. 209.9 ± 55.1 μm; supranasal, 237.7 ± 59.8 vs 209.3 ± 69.3 μm; infranasal, 172.6 ± 47.2 μm vs. 155.1 ± 38.2 μm (P < 0.001, for all). In patients with retinal fluid resolution, despite no apparent difference in baseline CT, there was more significant reduction after PDT in supratemporal and supranasal peripheral sectors, compared with patients without resolution: supratemporal, 41.9 ± 30.3 μm vs. -1.6 ± 22.7 μm; supranasal, 24.7 ± 15.3 μm vs. 8.5 ± 3.6 μm (P < 0.019, for both).

CONCLUSIONS

Whole CT decreased after PDT, including in medial areas from optic disc. This may be associated with the treatment response of PDT for CSC.

摘要

目的

通过超广角光学相干断层扫描(UWF-OCT)评估光动力疗法(PDT)治疗中心性浆液性脉络膜视网膜病变(CSC)后脉络膜的变化,探讨 PDT 对视盘内侧区域脉络膜的影响及其与治疗效果相关的因素。

方法

本回顾性病例系列研究纳入了接受标准剂量全光强 PDT 的 CSC 患者。治疗前和治疗后 3 个月进行 UWF-OCT 检查。我们测量脉络膜厚度(CT),并将其分为中央、中间和周边区。我们通过各区和治疗效果评估 PDT 后 CT 的变化。

结果

21 例患者(20 名男性;平均年龄 58.7 ± 12.3 岁)的 22 只眼纳入研究。所有区包括周边区(颞上、颞下、鼻上和鼻下)的 CT 在 PDT 后均显著降低:颞上,330.5 ± 90.6 μm 比 237.0 ± 53.2 μm;颞下,240.0 ± 89.4 μm 比 209.9 ± 55.1 μm;鼻上,237.7 ± 59.8 μm 比 209.3 ± 69.3 μm;鼻下,172.6 ± 47.2 μm 比 155.1 ± 38.2 μm(均 P < 0.001)。在视网膜液休吸收的患者中,尽管基线 CT 无明显差异,但与未吸收的患者相比,颞上和鼻上周边区的 CT 在 PDT 后下降更为明显:颞上,41.9 ± 30.3 μm 比 -1.6 ± 22.7 μm;鼻上,24.7 ± 15.3 μm 比 8.5 ± 3.6 μm(均 P < 0.019)。

结论

PDT 后全 CT 下降,包括视盘内侧区域。这可能与 PDT 治疗 CSC 的疗效有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6ee/9942968/d521367336ee/pone.0282057.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6ee/9942968/9057c0fa85ee/pone.0282057.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6ee/9942968/4aa2004e4246/pone.0282057.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6ee/9942968/c9f4724e1536/pone.0282057.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6ee/9942968/d521367336ee/pone.0282057.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6ee/9942968/9057c0fa85ee/pone.0282057.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6ee/9942968/4aa2004e4246/pone.0282057.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6ee/9942968/c9f4724e1536/pone.0282057.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6ee/9942968/d521367336ee/pone.0282057.g004.jpg

相似文献

1
Effect of photodynamic therapy on choroid of the medial area from optic disc in patients with central serous chorioretinopathy.光动力疗法对中心性浆液性脉络膜视网膜病变患者视盘内侧脉络膜的影响。
PLoS One. 2023 Feb 21;18(2):e0282057. doi: 10.1371/journal.pone.0282057. eCollection 2023.
2
Choroidal morphologic features in central serous chorioretinopathy using ultra-widefield optical coherence tomography.使用超广角光学相干断层扫描技术观察中心性浆液性脉络膜视网膜病变的脉络膜形态特征
Graefes Arch Clin Exp Ophthalmol. 2023 Apr;261(4):971-979. doi: 10.1007/s00417-022-05905-1. Epub 2022 Nov 19.
3
Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.特发性中心性浆液性脉络膜视网膜病变患者接受黄斑外光动力疗法治疗后脉络膜厚度的变化。
Acta Ophthalmol. 2012 Dec;90(8):738-43. doi: 10.1111/j.1755-3768.2011.02157.x. Epub 2011 May 17.
4
Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.聚焦式与传统维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的比较
Korean J Ophthalmol. 2019 Dec;33(6):506-513. doi: 10.3341/kjo.2019.0065.
5
Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.三分之一剂量维替泊芬光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的临床研究。
Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):278-284. doi: 10.26355/eurrev_201801_14169.
6
Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy.应用扫频源光学相干断层扫描评估光动力疗法治疗中心性浆液性脉络膜视网膜病变后的脉络膜地形图改变。
Am J Ophthalmol. 2014 Apr;157(4):852-60. doi: 10.1016/j.ajo.2013.12.029. Epub 2014 Jan 9.
7
Optical coherent tomographic angiographic pattern of the deep choroidal layer and choriocapillaris after photodynamic therapy for central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变光动力治疗后深层脉络膜层和脉络膜毛细血管的光学相干断层扫描血管造影模式
Graefes Arch Clin Exp Ophthalmol. 2019 Jul;257(7):1365-1372. doi: 10.1007/s00417-019-04318-x. Epub 2019 Apr 29.
8
Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.在慢性中心性浆液性脉络膜视网膜病变中,通过光学相干断层扫描血管造影和光学相干断层扫描评估半量光动力治疗后脉络膜的血管和结构改变。
Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):905-912. doi: 10.1007/s00417-018-04226-6. Epub 2019 Jan 7.
9
COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.使用半剂量维替泊芬或半光通量激光进行光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变的比较
Retina. 2017 Feb;37(2):325-333. doi: 10.1097/IAE.0000000000001138.
10
Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: Predisposing Factors for Visual Acuity Outcomes.半剂量光动力疗法治疗慢性中心性浆液性脉络膜视网膜病变:视力预后的易感因素
Semin Ophthalmol. 2018;33(5):690-699. doi: 10.1080/08820538.2017.1416414. Epub 2017 Dec 18.

引用本文的文献

1
Six-month outcomes of half-fluence photodynamic therapy combined with intravitreal Aflibercept injection for pachychoroid neovasculopathy.半剂量光动力疗法联合玻璃体内注射阿柏西普治疗厚脉络膜新生血管病变的六个月疗效
Graefes Arch Clin Exp Ophthalmol. 2025 Aug 25. doi: 10.1007/s00417-025-06945-z.
2
Reduction in choroidal thickness associated with the progression of pachychoroid spectrum diseases.脉络膜增厚相关疾病进展导致脉络膜厚度降低。
Jpn J Ophthalmol. 2025 Jun 14. doi: 10.1007/s10384-025-01230-2.
3
Central serous chorioretinopathy and the sclera: what we have learned so far.

本文引用的文献

1
Morphological differences of choroid in central serous chorioretinopathy determined by ultra-widefield optical coherence tomography.超宽视野光相干断层扫描对中心性浆液性脉络膜视网膜病变脉络膜形态差异的研究。
Graefes Arch Clin Exp Ophthalmol. 2022 Jan;260(1):295-301. doi: 10.1007/s00417-021-05380-0. Epub 2021 Aug 19.
2
Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial.半剂量光动力疗法与依普利酮治疗慢性中心性浆液性脉络膜视网膜病变(SPECTRA):一项随机对照试验。
Am J Ophthalmol. 2022 Jan;233:101-110. doi: 10.1016/j.ajo.2021.06.020. Epub 2021 Jun 29.
3
中心性浆液性脉络膜视网膜病变与巩膜:目前我们的认识。
Jpn J Ophthalmol. 2024 Sep;68(5):419-428. doi: 10.1007/s10384-024-01101-2. Epub 2024 Aug 16.
4
The Evaluation of Change in Choroidal Circulation Time before and after Half-Dose Photodynamic Therapy in Central Serous Chorioretinopathy Using Wide-Field Indocyanine Green Angiography.使用广角吲哚菁绿血管造影术评估中心性浆液性脉络膜视网膜病变患者半剂量光动力疗法前后脉络膜循环时间的变化
J Clin Med. 2024 Jul 21;13(14):4257. doi: 10.3390/jcm13144257.
5
One-year choroidal thickness changes after photodynamic therapy for central serous chorioretinopathy evaluated by widefield optical coherence tomography.用宽视野光学相干断层扫描评估光动力疗法治疗中心性浆液性脉络膜视网膜病变后一年的脉络膜厚度变化。
Graefes Arch Clin Exp Ophthalmol. 2024 Dec;262(12):3805-3814. doi: 10.1007/s00417-024-06578-8. Epub 2024 Jul 12.
6
Evaluating photodynamic therapy versus brolucizumab as a second-line treatment for polypoidal choroidal vasculopathy.评估光动力疗法与布罗珠单抗作为息肉样脉络膜血管病变二线治疗方法的疗效。
Int J Retina Vitreous. 2024 Apr 8;10(1):32. doi: 10.1186/s40942-024-00553-5.
7
Wide-Field Choroidal Thickness Analysis after Half-Fluence Photodynamic Therapy Combined with Intravitreal Aflibercept Injection in Pachychoroid Neovasculopathy.半剂量光动力疗法联合玻璃体内注射阿柏西普治疗厚脉络膜新生血管病变后的广域脉络膜厚度分析
J Clin Med. 2024 Mar 11;13(6):1608. doi: 10.3390/jcm13061608.
8
Attenuation of irradiated choroid and its regional vortex veins in central serous chorioretinopathy after photodynamic therapy.光动力疗法后中心性浆液性脉络膜视网膜病变中受辐照脉络膜及其区域性涡状静脉的衰减。
Sci Rep. 2023 Nov 14;13(1):19903. doi: 10.1038/s41598-023-47325-z.
Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.
慢性中心性浆液性脉络膜视网膜病变半剂量和三分之一剂量维替泊芬光动力疗法后脉络膜血流减少。
BMC Ophthalmol. 2021 May 31;21(1):241. doi: 10.1186/s12886-021-01980-w.
4
Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders.静脉超负荷性脉络膜病变:中心性浆液性脉络膜视网膜病变及相关疾病的一个假说框架
Prog Retin Eye Res. 2022 Jan;86:100973. doi: 10.1016/j.preteyeres.2021.100973. Epub 2021 May 21.
5
INTERVORTEX VENOUS ANASTOMOSIS IN Pachychoroid-RELATED DISORDERS.脉络膜增厚相关疾病的静脉吻合术
Retina. 2021 May 1;41(5):997-1004. doi: 10.1097/IAE.0000000000003004.
6
Vortex Vein Anastomosis at the Watershed in Pachychoroid Spectrum Diseases.脉络膜增厚谱病变中涡静脉吻合在分水岭区。
Ophthalmol Retina. 2020 Sep;4(9):938-945. doi: 10.1016/j.oret.2020.03.024. Epub 2020 Apr 6.
7
Quantitative analyses of diameter and running pattern of choroidal vessels in central serous chorioretinopathy by en face images.应用脉络膜血管图像对视盘中央浆液性脉络膜视网膜病变脉络膜血管直径和行径的定量分析。
Sci Rep. 2020 Jun 12;10(1):9591. doi: 10.1038/s41598-020-66858-1.
8
Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study.慢性中心性浆液性脉络膜视网膜病变光动力疗法后脉络膜解剖结构的改变:一项多中心研究。
Am J Ophthalmol. 2020 Sep;217:104-113. doi: 10.1016/j.ajo.2020.04.022. Epub 2020 Apr 28.
9
One-year outcome of combination therapy with intravitreal anti-vascular endothelial growth factor and photodynamic therapy in patients with pachychoroid neovasculopathy.玻璃体内抗血管内皮生长因子与光动力疗法联合治疗厚脉络膜新生血管病变患者的一年疗效
Graefes Arch Clin Exp Ophthalmol. 2020 Jun;258(6):1279-1285. doi: 10.1007/s00417-020-04661-4. Epub 2020 Mar 31.
10
CHANGES IN CHORIOCAPILLARIS, SATTLER, AND HALLER LAYER THICKNESSES IN CENTRAL SEROUS CHORIORETINOPATHY AFTER HALF-FLUENCE PHOTODYNAMIC THERAPY.中浆经半剂量光动力疗法治疗后脉络膜毛细血管层、Sattler 层和 Haller 层厚度的变化。
Retina. 2020 Dec;40(12):2373-2378. doi: 10.1097/IAE.0000000000002764.